Results 281 to 290 of about 176,622 (333)

Redefining Therapeutic Boundaries: PD-1 Blockade Facilitates Surgical Cure in EGFR-TKI Refractory EGFR-Mutant NSCLC with Pleural Metastases. [PDF]

Onco Targets Ther
Niu YL, Teng XB, Han MF, Ma J.
europepmc   +1 more source

Curcumin's Therapeutic Potential in Ovarian Cancer: Current Insights and Future Perspectives

Food Science &Nutrition, Volume 13, Issue 12, December 2025.
This review provides an overview of ovarian cancer, examines curcumin's emerging role in its treatment, identifies existing research gaps, and outlines a roadmap for future studies aimed at fully exploring curcumin's therapeutic potential in the management of ovarian cancer.
Smirnova Elena, Sureshbabu Anjana, Do Thi Cat Tuong, Sungyeon Chin, Mohammad Moniruzzaman, Bui Huy Doanh, Adhimoolam Karthikeyan, Taesun Min   +7 more
wiley   +1 more source

Bevacizumab and anlotinib combination therapy acts via HIF-1α suppression to exert synergistic anti-angiogenic and anti-tumor effects in non-small cell lung cancer. [PDF]

Front Immunol
Simayi N, Li J, Hu J, Jia N, Wan R, Xie J, Huang W.   +6 more
europepmc   +1 more source

Targeting the ST3 beta‐galactoside alpha‐2,3‐sialyltransferase 1 (ST3Gal1) as a potential therapeutic strategy to overcome anti‐VEGF resistance in endometrial cancer

International Journal of Gynecology &Obstetrics, Volume 171, Issue 3, Page 1343-1354, December 2025.
Abstract Objective To investigate the role of ST3 beta‐galactoside alpha‐2,3‐sialyltransferase 1 (ST3Gal1) in endometrial cancer (EC) progression and its potential as a therapeutic target to enhance the efficacy of antiangiogenic treatment. Methods ST3Gal1 expression and its clinical relevance were analyzed in EC tissues.
Chia‐Hao Liu, Szu‐Ting Yang, Wei‐Ting Chao, Chen‐Hao Lin, Yu‐Chieh Lee, Chiung‐Ru Lai, Shie‐Liang Hsieh, Liang‐Wei Wang, Peng‐Hui Wang   +8 more
wiley   +1 more source

Cerebral radiation necrosis successfully treated with high-dose bevacizumab. [PDF]

Respir Med Case Rep
Kugimiya K, Tsubouchi H, Saito K, Kadota Y, Azuma M, Sakai K, Oda Y, Sumiyoshi M, Yanagi S, Miyazaki T.   +9 more
europepmc   +1 more source

Intrathecal pemetrexed in patients with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) resistant refractory leptomeningeal metastasis lung adenocarcinoma: a retrospective study. [PDF]

J Thorac Dis
Yao R, Lin H, Li J, Ge M, Liang X, Zhou X.   +5 more
europepmc   +1 more source

Intravitreal Bevacizumab Alone Vs Combined With Topical Timolol-Dorzolamide or Dorzolamide for Diabetic Macular Edema: A Systematic Review and Meta-Analysis

Rahaf A Hubayni, Jumanah Qedair, Ziad M Bukhari, Ali S Alsudais, Orjwan Salah Badghaish, Razan Bawazir, Abdullah Alqahtani, Hashem Almarzouki   +7 more
openalex   +1 more source

Durable clinical benefit from gefitinib plus bevacizumab in a non-small cell lung cancer patient with an acquired C797S mutation following osimertinib treatment: a case report and literature review. [PDF]

Front Oncol
Tan Y, Dong M, Li X, Li W, Xiong F, Bao W, Dai Y, Yue L, Liu Y.   +8 more
europepmc   +1 more source

Real-World Comparative Study of Atezolizumab-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer. [PDF]

Cancers (Basel)
Ohiwa A, Nishimura T, Sakaguchi T, Fujimoto H, Kodama S, Fujiwara A, Nakahara H, Isobe T, Hirai T, Yagi A, Ebihara A, Ibata H, Hataji O, Yoshida M, Yuda H, Yasuma T, D'Alessandro-Gabazza CN, Gabazza EC, Kobayashi T.   +18 more
europepmc   +1 more source

Supplementary Data File 2 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma

William Kelly, Adolfo Enrique Diaz Duque, Joel Michalek, Brandon Konkel, Laura Caflisch, Yidong Chen, Sarath Chand Pathuri, Vinu Madhusudanannair-Kunnuparampil, John Floyd, Andrew Brenner   +9 more
openalex   +1 more source